FDA approves UZEDY ® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to ...

In REPO, there are many items you can buy that can affect your run. While you’ll want to get upgrades and health often, many other useful items can be purchased too. One of the more obscure items to ...

The AI features in web browsers, particularly in browsers like Edge, are designed to automate repetitive or monotonous tasks. Follow the complete guide to know how and where to use these AI features.

Blueprint Fragments in Rust are a brand-new addition to the game. They have been introduced with the latest Meta Shift update for the title, and are set to improve and change up how Rust is played ...

Microsoft has launched AI agents for Word, Excel, and PowerPoint. The agents are available for business and individual subscribers. Now accessible on the web, the agents will expand to the desktop.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Imagine how much you could ...

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I ...

(MENAFN- GetNews) Mordor Intelligence has published a new report on sterile injectable drugs market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction ...

U.S. Injectable Compounding Pharmacy Market estimated valued USD 1,745.4 Mn in 2025 & expected reach USD 2,858.2 Mn by 2032, growing CAGR of 7.3% from 2025-2032 BURLINGAME, CA, UNITED STATES, ...

Global pharma major Lupin Limited (Lupin) announced the launch of a strategic partnership programme aimed at expanding the reach of PrecisionSphere – the long-acting injectable (LAI) platform ...

UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults. 1 This approval marks a ...